Study, No Quantifiable Benefits from COVID Treatment Drug Paxlovid for People Aged 40 to 65

[BACK]
Study, No Quantifiable Benefits from COVID Treatment Drug Paxlovid for People Aged 40 to 65
Posted On: August 26, 2022
In April 2022, the Biden administration ordered 20 million doses of Pfizer’s antiviral Covid-19 treatment called Paxlovid. Now a study published in the New England Journal of Medicine shows the medication shows “no measurable benefit” for the treatment of COVID-19 in patients 40 to 65-years of age. WASHINGTON — Pfizer’s COVID-19 pill appears to provide […] The post Study, No Quantifiable Benefits from COVID Treatment Drug Paxlovid for People Aged 40 to 65 appeared first on The Last Refuge.

Re Posted From: Study, No Quantifiable Benefits from COVID Treatment Drug Paxlovid for People Aged 40 to 65

The Last Refuge

[BACK]
Study, No Quantifiable Benefits from COVID Treatment Drug Paxlovid for People Aged 40 to 65
Posted On: August 26, 2022
In April 2022, the Biden administration ordered 20 million doses of Pfizer’s antiviral Covid-19 treatment called Paxlovid. Now a study published in the New England Journal of Medicine shows the medication shows “no measurable benefit” for the treatment of COVID-19 in patients 40 to 65-years of age. WASHINGTON — Pfizer’s COVID-19 pill appears to provide […] The post Study, No Quantifiable Benefits from COVID Treatment Drug Paxlovid for People Aged 40 to 65 appeared first on The Last Refuge.

Re Posted From: Study, No Quantifiable Benefits from COVID Treatment Drug Paxlovid for People Aged 40 to 65

The Last Refuge

[BACK]
TOP